Perrigo (PRGO) Competitors

Jazz Pharmaceuticals (NASDAQ:JAZZ) and Perrigo (NYSE:PRGO) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, community ranking, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

Do analysts prefer JAZZ or PRGO?

Jazz Pharmaceuticals currently has a consensus target price of $177.00, indicating a potential upside of 46.81%. Perrigo has a consensus target price of $37.00, indicating a potential upside of 42.58%. Given Jazz Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Jazz Pharmaceuticals is more favorable than Perrigo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jazz Pharmaceuticals	0 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.87
Perrigo	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Which has higher valuation and earnings, JAZZ or PRGO?

Jazz Pharmaceuticals has higher earnings, but lower revenue than Perrigo. Perrigo is trading at a lower price-to-earnings ratio than Jazz Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jazz Pharmaceuticals	$3.99B	1.83	$414.83M	$7.10	16.98
Perrigo	$4.39B	0.81	-$12.70M	-$1.17	-22.18

Does the media favor JAZZ or PRGO?

In the previous week, Jazz Pharmaceuticals had 1 more articles in the media than Perrigo. MarketBeat recorded 4 mentions for Jazz Pharmaceuticals and 3 mentions for Perrigo. Jazz Pharmaceuticals' average media sentiment score of 0.62 beat Perrigo's score of 0.53 indicating that Jazz Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Jazz Pharmaceuticals	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Perrigo	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is JAZZ or PRGO more profitable?

Jazz Pharmaceuticals has a net margin of 11.60% compared to Perrigo's net margin of -3.64%. Jazz Pharmaceuticals' return on equity of 29.30% beat Perrigo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jazz Pharmaceuticals	11.60%	29.30%	9.72%
Perrigo	-3.64%	7.38%	3.18%

Does the MarketBeat Community prefer JAZZ or PRGO?

Jazz Pharmaceuticals received 355 more outperform votes than Perrigo when rated by MarketBeat users. Likewise, 80.76% of users gave Jazz Pharmaceuticals an outperform vote while only 66.55% of users gave Perrigo an outperform vote.

Company	Underperform	Outperform
Jazz Pharmaceuticals	Outperform Votes 1125 80.76%	Underperform Votes 268 19.24%
Perrigo	Outperform Votes 770 66.55%	Underperform Votes 387 33.45%

Which has more risk and volatility, JAZZ or PRGO?

Jazz Pharmaceuticals has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500. Comparatively, Perrigo has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500.

Do institutionals & insiders hold more shares of JAZZ or PRGO?

89.1% of Jazz Pharmaceuticals shares are held by institutional investors. Comparatively, 95.9% of Perrigo shares are held by institutional investors. 4.2% of Jazz Pharmaceuticals shares are held by company insiders. Comparatively, 0.7% of Perrigo shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Jazz Pharmaceuticals beats Perrigo on 16 of the 18 factors compared between the two stocks.